A practical development route for skincare brands preparing products for the EU, Great Britain and Northern Ireland markets.
INTE supports formula development, factory documentation, testing coordination, packaging information and production readiness. The appointed Responsible Person and qualified safety assessor remain responsible for the final regulatory decision.
EU and UK skincare projects involve more than formula development and manufacturing. The formula, ingredients, packaging, label information, testing plan and regulatory route need to be aligned before the product is released for commercial production.
INTE helps brands organize the factory-side and product-side information required for regulatory review, while keeping the responsibilities of the manufacturer, Responsible Person and safety assessor clearly separated.
Translate a product brief, benchmark sample or product concept into a feasible formula and packaging direction.
Prepare manufacturing, ingredient, packaging and testing information for the appointed regulatory parties.
Coordinate final formula confirmation, artwork review, testing status and production details before bulk manufacturing.
A reliable OEM project should make it clear which information is provided by the factory and which decisions must be made by the appointed regulatory parties.
INTE does not act as the Responsible Person. We provide the factory-side and product-side technical information required by the appointed Responsible Person and qualified safety assessor.
The most efficient projects do not wait until the end of development to consider compliance. Testing, packaging review and regulatory preparation should be planned alongside formula development.
Confirm product category, target consumer, intended claims, target market, texture, ingredients and expected launch timing.
Review a new concept, existing formula or benchmark sample and confirm the appropriate development route.
Review fill format, primary packaging, compatibility considerations, decoration and required label information.
Plan stability, microbiological, packaging compatibility and claims-supporting testing where relevant.
Confirm the EU or GB Responsible Person and the address that will be used on the product packaging.
Review mandatory product information and approve print-ready artwork only after RP details are confirmed.
Provide product information for CPSR, PIF, CPNP or SCPN preparation by the appointed regulatory parties.
Confirm formula, packaging, testing status, artwork and production details before commercial manufacturing.
Before a skincare product moves into production, the factory-side information must be complete enough for the Responsible Person and safety assessor to review.
Regulatory preparation and product testing should not be treated as two completely separate stages. The testing plan should be considered while the formula and packaging are being finalized.
Where relevant, testing should be carried out using the final formula and final packaging configuration. Changes after testing may require additional review or repeat testing.
A practical project separates the technical documents provided by the manufacturer from the market-specific documents finalized by the Responsible Person and safety assessor.
One of the most common sources of avoidable packaging rework is approving the label before the Responsible Person has been confirmed.
Decide whether the product is intended for the EU, Great Britain, Northern Ireland or multiple markets.
Confirm the legal name and address of the appointed Responsible Person before approving final artwork.
Review mandatory product information and only then release the artwork for printing and production.
EU, Great Britain and Northern Ireland should not be treated as one single regulatory route. The Responsible Person, notification process and safety review should be confirmed according to the actual destination market.
| Market | Main Notification Route | Responsible Person and Review |
|---|---|---|
| EU Member States | CPNP | An EU-established Responsible Person handles the applicable EU notification and regulatory responsibilities. |
| Great Britain | SCPN | A UK-established Responsible Person is required. The product requires a GB-specific regulatory review. |
| Northern Ireland | Separate route assessment | The applicable EU or NI route should be confirmed separately according to the product and market arrangement. |
An EU CPSR should not be assumed to automatically cover Great Britain. The product should undergo a GB-specific review, adaptation or re-signing where required by the qualified safety assessor and UK Responsible Person.
INTE does not act as the Responsible Person. We provide the product, manufacturing and technical information required by the appointed regulatory parties.
For products placed on the EU market, the EU Responsible Person is responsible for submitting the required product information to the Cosmetic Products Notification Portal, or CPNP, before the product is placed on the market.
Product name, category, Responsible Person details and the market in which the product will be made available.
The applicable formula information and, where required, the frame formulation for emergency medical treatment.
Formula-related information is handled between the brand, manufacturer and regulatory parties under agreed confidentiality arrangements.
The frame formulation is not the same as publishing the full commercial formula. INTE can prepare and provide the relevant product information required for regulatory review, while the EU Responsible Person remains responsible for the final CPNP notification.
For EU market entry, animal-testing compliance should be considered at both finished-product and ingredient level.
INTE can coordinate available supplier declarations and traceability documents for review. The final interpretation and acceptance of the evidence must be made by the Responsible Person and qualified safety assessor.
Before approving mass production, we recommend confirming the following items with your project team and regulatory partners.
The EU or GB Responsible Person has been appointed and the legal address is confirmed.
The formula, ingredients, fragrance and preservative system have been finalized.
The primary packaging and compatibility requirements have been reviewed.
Stability, microbiological, compatibility and claims-supporting testing has been planned where relevant.
The EU, GB or NI route has been clearly defined and the required regulatory parties are aligned.
The mandatory label information has been reviewed before the artwork is released for printing.
No. INTE does not act as the Responsible Person. We provide factory-side and product-side technical information for the appointed Responsible Person and qualified safety assessor.
An EU CPSR should not be assumed to automatically cover Great Britain. The project should be reviewed for GB requirements and adapted or re-signed where required by the qualified safety assessor and UK Responsible Person.
The Responsible Person should ideally be confirmed before the final packaging artwork is approved. The RP name and address may need to appear on the product packaging.
A frame formulation is formula information used for the EU notification process and intended to support prompt and appropriate medical treatment in the event of difficulties. It is not the same as publishing the full commercial formula.
Testing should be planned during formula and packaging development. Where relevant, final testing should use the final formula and final packaging configuration.
INTE can provide relevant factory-side GMP / ISO 22716-related documentation and manufacturing information for regulatory review, subject to the project scope and the applicable certified manufacturing entity.
INTE can coordinate available supplier declarations, traceability documents and factory-side information for review. Final interpretation and acceptance remain with the Responsible Person and qualified safety assessor.
Share your product concept, target market, preferred formula or benchmark, packaging direction, expected quantity and target launch date. Our team will help you identify the appropriate development, testing and manufacturing route.
Request an EU/GB Readiness ReviewCopyright © 2025 by Inte Cosmetics (shenzhen) Co., Ltd.